Header graphic for print


Healthcare reform winners & losers

Capital Thinking: Health Care Legislative Update

Posted in Uncategorized

Lawmakers Continue Negotiations on Doc Fix Package, Working Framework Announced

With the current patch expiring on March 31, lawmakers continued over the weekend to negotiate a legislative package to permanently repeal Medicare’s automatic payment cut to physicians. H.R. 1470 is very similar to the bipartisan legislation that key committees in both chambers approved last year. It provides an annual pay increase of 0.5 percent to physicians through 2019 and establishes an incentive payment program, titled “Merit-Based Incentive Payment System” (MIPS), to assess eligible professionals in quality, resource use, electronic health record (EHR) Meaningful Use (MU), and clinical practice improvement activities. It consolidates three current incentive programs – the Physician Quality Reporting System (PQRS), the Value-Based Modifier, and MU of EHRs. The legislation also provides financial incentives for professionals to become involved in alternative payment models.

Other provisions of H.R. 1470 address care management for individuals with chronic care needs, transparency of utilization and payment data for physicians and professionals, expansion of claims data availability, automatic renewal for professionals who opt-out of Medicare, and the reporting of such professional characteristics. The bill requires EHRs to be interoperable by 2018 and prohibits the purposeful blocking of information sharing with other EHR vendor products. The Secretary of the Department of Health and Human Services is required to issue a report providing recommendations on a permanent physician-hospital gainsharing program, as well as a report to examine the feasibility of establishing mechanisms to assist providers in comparing and selecting EHR technology products. The Government Accountability Office is to report on aspects of telehealth and remote patient monitoring services.

The working summary of the SGR package released by the House committee leaders includes fully funding the Children’s Health Insurance Program (CHIP) through September 30, 2017. It extends all of the extenders in the current patch, in addition to funding for Community Health Centers, through 2017. The framework would permanently extend the Qualifying Individual Program and the Transitional Medical Assistance program, and the Tennessee Disproportionate Share Hospital (DSH) Allotment would be extended through 2015. The legislation also includes two Medicare bills: H.R. 284, the Medicare DMEPOs Competitive Bidding Improvement Act and H.R. 1021, the Protecting Integrity to Medicare Act.

The policies that reduce the legislation’s cost that are provided in the working framework include: income-related Medicare Part B and D premium adjustments, Medigap reforms, an increase of levy authority on payments to Medicare providers with delinquent tax debt, an incremental phase-in of the 3.2 percentage point adjustment to hospital’s base payment rate in FY 2018, a delay of Medicaid DSH changes until FY 2018 and extension of the policy through 2025, and a 1 percent market basket update for post-acute care providers.

Negotiations are steadily making progress, and the House could consider the legislation as early as this week. Notably, Democrats on the Senate Committee on Finance have expressed concerns about the current package, including the two-year extension of the Children’s Health Insurance Program (CHIP) (where they would like a four-year extension), offsets that would increase costs to beneficiaries, and the impact of health centers language on women’s health services. On the other side of the aisle, some conservative lawmakers remain concerned about the cost of the total proposed package and the potential approach that would only provide for partial offsets.

This Week’s Hearings:

  • Tuesday, March 24: The House Committee on Ways and Means Subcommittee on Oversight will hold a hearing titled “The Use of Data to Stop Medicare Fraud.”
  • Tuesday, March 24: The House Committee on Agriculture will hold a hearing titled “Examination of the Costs and Impacts of Mandatory Biotechnology Laws.”
  • Tuesday, March 24: The House Committee on Energy and Commerce Subcommittee on Health will hold a hearing titled “Examining the 340B Drug Pricing Program.”
  • Tuesday, March 24: The Senate Committee on Health, Education, Labor, and Pensions (HELP) will hold a hearing titled “Continuing America’s Leadership: Advancing Research and Development for Patients.”
  • Tuesday, March 24: The Senate Committee on Veterans’ Affairs will hold a hearing titled “The Veterans Choice Act – Exploring the Distance Criteria.”
  • Wednesday, March 25: The House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies will hold a hearing titled “Centers for Disease Control and Prevention Budget.”
  • Wednesday, March 25: The House Committee on Veterans’ Affairs will hold a hearing titled “Examining Access and Quality of Care and Services for Women Veterans.”
  • Wednesday, March 25: The Senate Committee on Appropriations Subcommittee on Defense will hold a hearing to review the FY 2016 funding request and budget justification for the Defense Health Program.
  • Wednesday, March 25: The Senate Committee on Aging will hold a hearing titled “The Fight Against Alzheimer’s Disease: Are We on Track to a Treatment by 2025?”
  • Thursday, March 26: The House Committee on Energy and Commerce Subcommittee on Oversight and Investigations will hold a hearing titled “Examining the Growing Problems of Prescription Drug and Heroin Abuse: State and Local Perspectives.”
  • Thursday, March 26: The House Committee on Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies will hold a hearing titled “Federal Investments in Neuroscience and Neurotechnology Oversight.”
  • Thursday, March 26: The Senate Committee on Veterans’ Affairs will hold a hearing titled “VA Opioid Prescription Policy, Practice, and Procedures.”

Capital Thinking: Health Care Legislative Update

Posted in Uncategorized

Congressmen Negotiate SGR Package

Lawmakers on the House side of the Capitol continue to negotiate a package that would prevent an anticipated cut to Medicare physician payments and include a permanent repeal of payment system. Bipartisan leaders on the House Committee on Ways and Means and the House Committee on Energy and Commerce released joint statements on Friday afternoon confirming ongoing discussions to permanently repeal the Sustainable Growth Rate (SGR) formula. If the negotiations are fruitful, legislation could be released in the House this coming week. Some conservative lawmakers have expressed concern over the cost of the proposed package and a potential approach that would only provide for partial offsets. Senate Democrats have also expressed concern over various elements of the package, including offsets that would cut Medicare benefits and a short-term extension of the Children’s Health Insurance Program (CHIP). The current patch expires on March 31.

House Considers Trauma Bills

On Monday, the House will consider several health care bills under suspension of the rules: H.R. 639, Improving Regulatory Transparency for New Medical Therapies Act, as amended; H.R. 647, Access to Life-Saving Trauma Care for All Americans Act; H.R. 648, Trauma Systems and Regionalization of Emergency Care Reauthorization Act; H.R. 284, Medicare DMEPOS Competitive Bidding Improvement Act of 2015, as amended; and H.R. 876, Notice of Observation Treatment and Implication for Care eligibility Act, as amended.

This Week’s Hearings:

  • Tuesday, March 17: The Senate Committee on Health, Education, Labor, and Pensions (HELP) will hold a hearing titled “America’s Health IT Transformation: Translating the Promise of Electronic Health Records Into Better Care.”
  • Thursday, March 19: The Senate Committee on Finance will hold a hearing titled “The Affordable Care Act at Five Years.”

US Supreme Court Oral Argument on Tax Subsidies for Federal Exchange

Posted in ACA, Insurance, PPACA

This morning, the U.S. Supreme Court heard oral argument in King v. Burwell, which raises the issue of whether the federal government can provide tax subsidies to people who buy insurance on the federal exchange because their state declined to establish its own insurance exchange.  Our earlier post details  the arguments at play.  SCOTUS Blog has extensive analysis of the oral argument and what can be read into the various questions and answers.  In addition, Reuters speculates that the four Democratic appointees to the Court will rule in favor of the subsidies, and of the five Republican appointees, Chief Justice Roberts and Justice Kennedy are potential swing votes that could tip the scales one way or the other.

The written transcript will be available today.  On Friday, audio of the argument will be available here after being released by the Court, which notably declined requests to release the audio the same day as the argument like it did in the constitutionality cases.  But, only the Justices and their clerks will know the outcome until June, when a decision is expected to be issued in the final days of the Court’s term.

Commentary on the case is everywhere (the SCOTUS blog has a good collection in their Wednesday round-up), ranging from forecasts of who might win, how the individual Justices may vote, what might happen to exchange coverage if the subsidies are taken away, and whether Congress or the Obama administration have contingency plans if the subsidies disappear.  The periodic barrage of commentary is likely to continue in the press until a decision comes out.  In the meantime, insurers will certainly be doing contingency planning of their own, though it will likely be quieter than the political debate.

Capital Thinking: Health Care Legislative Update

Posted in Uncategorized

All Eyes On The Supreme Court

On Wednesday, March 4, the attention of many lawmakers will turn to the Supreme Court, where oral arguments are slated for the statutory interpretation case of King v. Burwell. The issue in this case is whether the Affordable Care Act (ACA) provides tax subsidies to individuals who purchase insurance through the federal exchange, in addition to the subsidies for those who purchase insurance through state-based exchanges, which is explicitly stated in the law. Since implementation of the ACA, individuals meeting certain income levels who buy insurance through either a state- or federally-administered exchange have been receiving tax subsidies, pursuant to Internal Revenue Service (IRS) interpretation. However, the plaintiffs in King argue that the statute only provides subsidies to people who purchase insurance from “an Exchange established by the State,” as written in plain English in the health reform law. The government contends that the legislative intent of the law was to treat all exchanges in the same manner with regard to subsidies and that this one cited phrase is contradicted by the rest of the law.

It has been estimated that seven to eight million people would lose their subsidies if the Supreme Court rules against the Administration. This decision could be a detriment to Republican legislators, who are eager to see the ACA repealed but do not want to face the wrath of voters losing their health insurance. While the Administration insists it does not have a contingency plan if the federal subsidies are indeed found to be outside of statutory authority, Republicans such as House Committee on Ways and Means Chairman Paul Ryan (R-WI) and Senate Committee on Finance Chairman Orrin Hatch (R-UT) have publicly stated the need for and their intent to form a contingency plan.

This Week’s Hearings:

  • Tuesday, March 3: The House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies will hold a hearing on “National Institutes of Health.”
  • Wednesday, March 4: The House Committee on Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies will hold a hearing on “Food and Drug Administration Budget.”
  • Thursday, March 5: The House Committee on Energy and Commerce Subcommittee on Health will hold a hearing titled “Examining the 340B Drug Pricing Program.”
  • Thursday, March 5: The Senate Committee on Health, Education, Labor, and Pensions (HELP) will hold a hearing titled “America’s Health IT Transformation: Translating the Promise of Electronic Health Records Into Better Care.”

CMS delays identifying overpayments. Can you?

Posted in Compliance, Department of Health and Human Services, False Claims Act, Fraud and Abuse

The Centers for Medicare and Medicaid Services (CMS) continues to mull over the knotty problem of what it means to identify an overpayment from the government.  Healthcare providers do not have the same luxury.

Five  years ago, the Affordable Care Act required a provider that received an overpayment from the government to report and repay it within 60 days of identifying the overpayment. 42 U.S.C. 1320a-7(k)(d). Not satisfied with simply requiring prompt repayment, Congress also decreed that failure to make repayment within the 60-day limit creates potential liability under the False Claims Act.  80 FR 8248.  In 2012, CMS stirred up controversy when it issued draft guidance implementing the 60-day rule.  77 FR 9179.  The proposal was never finalized. 80 FR 8248In an unusual move, CMS recently announced that it will postpone its rulemaking for yet another year beyond the normal three year limit.  80 FR 8247.

Like CMS, each provider must grapple with the question of whether an overpayment has been identified, even though that term is not defined in the statute.  Whatever its details, the CMS rulemaking is certain to require an organization to make a reasonable inquiry into information it has received about an overpayment rather than hide its head in the sand (known legally as deliberate ignorance or willful blindness).

Although CMS may have postponed its implementing regulations, the statutory mandate is in effect.  80 FR 8248. Relators and the government have begun seeking up to treble damages by litigating against providers for failure to make timely repayment.  For example, the government recently intervened after a relator sued Continuum Health Partners, Inc. in New York.  See Complaint

That litigation illustrates that relators and the Department of Justice are not waiting for CMS and neither can you.  Despite uncertainty about how the regulations will try to incorporate the incredible variety of situations possible in health care, each provider must remain vigilant about identifying and returning overpayments it may have received from the government or face the enhanced penalties that may result.


Anthem Data Breach: A Dramatic Reminder about Data Security

Posted in Data Protection, HIPAA, Privacy

News of the data breach suffered by Anthem continues to dominate the news (here, here, and here for example).  And, further raising the stakes, class action lawsuits from individuals whose information has potentially been compromised are beginning to roll into courthouses across the country (California, Alabama, Indiana, Georgia, California (again), and California (again)).  Because health care data is such a hot commodity on the black market, hackers often target health care providers and other entities who have health care data.  Data breaches aimed at health care information were way up last year, and attempted data breaches are only expected to increase.

Encryption, which Anthem didn’t have according to news reports, goes a long way toward securing this sensitive data.  However, even with encryption, it is worthwhile for  providers large and small to review existing data security/breach response policies or institute new ones targeted at current technologies.   Considerations include:

  • Organize your data network and know what information you have and where it is (including technologies like cloud computing, printer/copiers, and employees’ mobile devices);
  • Update encryption, password, and remote access policies and ensure they are followed;
  • Perform a risk assessment (and document it);
  • Create a protocol to monitor unauthorized attempts to access data;
  • Develop a plan to respond to a data breach, including technical, legal, and business continuation considerations;
  • Plan for disclosures to employees, shareholders, individuals effected, media, and/or federal regulators as required
  • Review state laws that may apply for additional reporting or safeguard requirements

For additional discussion, you can access recordings of our two-part webinar series on data security planning and response for healthcare providers, presented by Tom Zeno and Emily Root, along with Thomas Hibarger (Managing Director of Stroz Friedberg), and Justin Root, Special Agent – Cyber Crimes with the Office of Ohio Attorney General:

What Keeps You Up at Night: My Data’s Been Stolen: Now What? – Part I (materials and recording)

What Keeps You Up at Night: My Data’s Been Stolen: Now What? – Part II (materials and recording)

FDA Rethinks Consumer-Directed Print Ads for Drugs

Posted in Uncategorized

In 2004, the FDA promulgated requirements for drug print advertisements.  FDA, 69 Fed. Reg. 6307 (May 10, 2004).  Those regulations required “the entire risk-related sections of the FDA-approved professional labeling.”  The FDA is now significantly changing its course because of  “recent social science research” indicating that non-material information should be omitted from drug advertisements in print in order to be more effective for consumers.  FDA, 80 Fed. Reg. 6998-99 (Feb. 9, 2015).  Instead of listing all risks, the FDA is recommending that any print advertisement display:

  • The most serious and the most common risks associated with the product, while omitting less important information.
  • The indication for the use being promoted.
  • The information regarding patient directives (such as “discuss with your health care provider any pre-existing conditions” or “tell your health care provider if you are taking any medications”).
  • A statement that more comprehensive information can be obtained from various sources, including the manufacturer.

In addition to focusing on the most important risks, the FDA wants the information “presented in a way most likely to be understood by consumers.”  However, the draft recommendation does not provide much guidance to manufacturers on how to do that.  The burden will be on manufacturers to sort out what risks can be omitted and how to write in plain language “most likely to be understood by consumers.” 80 Fed. Reg. 6999.

These requirements would be permissive, and drug manufacturers could include more information if they desire. The FDA is currently seeking comments on the proposal.

The FDA’s revised draft guidance document, Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Human Prescription Drugs, details the proposed changes.


Significant Changes to RAC Contracts Announced

Posted in Compliance, Fraud and Abuse

Just before the ball dropped to start the new year, the Centers for Medicare & Medicaid Services approved the Recovery Audit Contractor (RAC) to identify and recoup improper payments for durable medical equipment, home health and hospice care on a national basis (known as region 5). The contract, dated December 30, 2014, is the first one issued since Recovery Audit contracts were halted last summer. Providers must be vigilant when responding to an audit both because of the value of claims being questioned, but also because these audits can lead to civil and criminal fraud investigations.

Fortunately, the new contract incorporates changes addressing provider concerns with prior RAC arrangements, and these changes will apply to all future contracts with RACs. Other contracts have been delayed because of contract protest litigation.

Notable changes to the contracts will include:

  • Limiting the size of Additional Document Requests based upon the denial record of the provider; lower denial rates mean lower document limits;
  • Limiting the look back-period to six months from the date of service for hospital claims submitted within three months of the date of service;
  • Imposing a 30 day delay to allow for a discussion request by the provider before a RAC can send a denial to be processed by the Medicare Administrative Contractor;
  • Withholding payment of the contingency fee to the RAC until after a claim has gone through the second level of appeals; and
  • Requiring RACs to maintain an accuracy rate of at least 95% and penalizing RACs for high overturn rates on appeal.

A detailed list of the changes can be found here.

IRS Releases Final Regulations for IRS Code Section 501(r)

Posted in ACA, Compliance, Hospitals, Tax, Uncategorized

On December 29th, the IRS released final regulations regarding Internal Revenue Code Section 501(r).  Section 501(r) was added to the Code as part of the Accountable Care Act and imposes certain requirements on charitable hospitals.   In general, the final regulations provide guidance on hospital obligations under Section 501(r), define the types of entities that must comply with these obligations, and describe the consequences for failing to meet Section 501(r)’s requirements.

More specifically, the final regulations include provisions addressing the following:

  • A definition of what constitutes a “hospital organization” and “hospital facility” under Section 501(r);
  • Guidance relating to minor errors and omissions under Section 501(r)’s disclosure requirements;
  • Provisions regarding the preparation and documentation of Community Health Needs Assessments (“CHNAs”);
  • Guidance regarding development of a Financial Assistance Policy (“FAP”), including eligibility criteria, publicizing the FAP, and development of emergency care policies;
  • Limitations on charges to FAP eligible individuals; and
  • Limitations on billing and collection activities relating to FAP eligible individuals.

The final regulations relating to Section 501(r) will be applicable to hospital facilities for the taxable year beginning after December 29, 2015.  A copy of the final regulations may be found here.



CMS Issues Post Windsor Guidance Regarding Same-Sex Spouses

Posted in Uncategorized

The Centers for Medicare and Medicaid (“CMS”) issued a proposed rule broadening the definitions of “representative” and “spouse” in its Medicare and Medicaid conditions of participation and conditions of coverage in response to United States v. Windsor, 570 U.S. 12 (2013) — the U.S. Supreme Court  decision striking down Section 3 of the Defense of Marriage Act (DOMA), which banned federal benefits for same-sex spouses, as unconstitutional.

This proposed rule will apply to all hospitals, ambulatory surgical centers, hospices, long-term care facilities, and community mental health centers as a condition for participation in the Medicare and Medicaid programs. Under the proposed rule, institutions that participate in Medicare and Medicaid must respect same-sex spouses’ decisions to designate their spouse as a “representative” or “spouse” as long as the couple is legally married “under the law of the state, territory, or foreign jurisdiction where the marriage was entered into.” CMS followed other administrative agencies that have used the place of celebration as the test for a valid marriage. This “state of celebration rule” extends to same-sex couples who reside in or seek treatment in a state that does not legally recognize their marriage. Now all spouses, regardless of sexual orientation, will be able to participate in various aspects of their spouse’s health care, including visitation and decision-making.

As the proposed rule currently reads, there are no exemptions for small or religious-based institutions. However, this issue may not be as charged as it once was, as one catholic health-care network will be offering health care benefits to same-sex spouses and domestic partners as of January 2015, which leads to the inference catholic institutions may no longer desire to use sexual orientation as a basis to treat individuals differently. Although it is only one at this point, others may soon follow suit. Moreover, it may be difficult to challenge this broad rule, as the Secretary of Health and Human Services’ (the “Secretary”) authority stems from various provisions of the Social Security Act, which authorizes the Secretary to establish requirements necessary in the interest of the health and safety of patients and agencies are given high deference in the rule-making process.

This proposed rule is open for comment for 60 days.